Robert Cavorsi
Corporate Officer/Principal presso ORGANOGENESIS HOLDINGS INC.
Patrimonio netto: 157 944 $ in data 31/05/2024
Profilo
Robert Cavorsi is currently the Vice President-Strategy at Organogenesis Holdings, Inc. He previously worked as the Neurology Director-Sales Operations at Sumitomo Pharma America, Inc. from 2015 to 2016.
He obtained his undergraduate degree from The Pennsylvania State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 19/04/2024 | 57 434 ( 0.04% ) | 157 944 $ | 31/05/2024 |
Posizioni attive di Robert Cavorsi
| Società | Posizione | Inizio |
|---|---|---|
| ORGANOGENESIS HOLDINGS INC. | Corporate Officer/Principal | 01/01/2021 |
Precedenti posizioni note di Robert Cavorsi
| Società | Posizione | Fine |
|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Vendite & Marketing | 01/01/2016 |
Formazione di Robert Cavorsi
| The Pennsylvania State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ORGANOGENESIS HOLDINGS INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
- Borsa valori
- Insiders
- Robert Cavorsi
